(Received for publication, March 16, 1944) Liver injury is not an uncommon complication following the use of such drugs as chloroform, arsenical compounds, and carbon tetrachloride. It also occurs in various degrees of severity as the result of toxic materials elaborated within the body due to infection. In the past the clinician has utilized carbohydrates to combat such damage and to aid in the repair of the already injured organ. More recently experimental work has shown that adequate protein is of the utmost importance. The value of carbohydrates may well be in their protein sparing effects.
Davis and Whipple (2) in 1919 demonstrated that carbohydrates protect against liver injury due to chloroform anesthesia, and aid in the regeneration following injury. In 1932 Schffrin (8) called attention to the value of protein in protecting the liver against arsphenamine injury. Goldschmidt, Vars, and Ravdin (4) added further evidence to the importance of protein, when in 1939 they reported that a high protein diet given previous to chloroform anesthesia reduces the incidence of hepatic cellular necrosis in rats. In 1940 Messinger and Hawkins (5) demonstrated the protective value of protein and carbohydrate against arsphenamine liver injury and also established the fact that fat is definitely deleterious. This report and that of Schifrin refuted the statement of Craven (1) that fat diets are most protective against arsphenamine liver damage. At the same time Miller and Whipple (7) reported that chloroform liver injury increases as protein stores decrease and that a protein meal prior to anesthesia is beneficial. Shortly thereafter Miller, Ross, and Whipple (6) demonstrated clearly that the sulphur-containing amino acids, methionine and cystine, are the specific protein factors and that methionine is more effective than cystine in protecting the livers of these protein-depleted dogs.
The experimental data given below indicate clearly that methionine protects against arsenic liver injury just as it does against chloroform injury. We have used mapharsen as the arsenical compound because of its widespread clinical use and ease of administration.
Methods
The dogs used in these experiments were active, healthy adults. Their plasma protein levels, before depletion was started, ranged from 5.10 to 6.52 gin. per cent.
* We are indebted to Merck and Company, Inc., for the methionine used in these experiments. 625
All dogs were fasted for 1 week, after which they were placed on the very low protein diet described below. In most cases the diet was taken fairly well, although a few dogs refused it after 4 or 5 weeks, and in these cases forced spoon feeding was required. Some of the dogs tolerated the diet well and remained in excellent clinical condition for as long as 10 to 12 weeks, while others became quiet and listless after 4 or 5 weeks. Blood samples were removed from the external jugular vein, using 1.4 per cent sodium oxalate as anticoagulant. During the period of depletion weekly plasma protein determinations were made by the macro Kjeldahl method without correcting for non-protein nitrogen. Weekly hematocrit determinations were also done. In a few instances, plasmapheresis was employed to effect a more rapid protein depletion. This procedure consisted of the removal of whole blood followed by the immediate return of a corresponding amount of red blood cells suspended in Locke's solution. Those dogs which were depleted by diet alone were maintained on the dietary regimen for a period of 5 to 10 weeks before mapharsen was administered; i.e., until their plasma protein levels were low enough to indicate that their protein stores were depleted. In those cases in which plasmapheresis was employed in addition to diet, a suitable level was reached in from 2 to 6 weeks. Mapharsen in distilled water solution (0.05 gm. per 10 cc.) was given intravenously in varying dosages. When methionine was used, it was either given by mouth 24 hours prior to the administration of mapharsen, or given intravenously (1.0 gm. in 25 cc. of distilled water) immediately before the administration of mapharsen. Dosages of mapharsen and methionine are given in the tables below.
The icteric index was estimated directly on plasma obtained from centrifugalized oxalated blood samples, comparing with color standards according to the method of Farahaugh and Medes (3).
The low protein diet used consisted of cane sugar, 5200 gm.; bone ash 156 gm.; salt mixture 156 gm.; yeast 52 gm.; liver extract 52 gin.; mazola oil 470 gm.; cod liver oil 100 gm.; lard 490 gin.; 2 cc. of choline hydrochloride and 4 cc. of nicotinic acid. Thus carbohydrate formed 72.5 per cent of the diet, fats about 20.2 per cent. Vitamins and minerals composed a large part of the remaining 7 per cent with a negligible quantity of protein present. The dogs were started on 6.6 gm. per kilo of this diet daily. In some instances, this was increased later because of weight loss.
EXPERIMENTAL OBSERVATIONS
It should be emphasized that the dosages of mapharsen used in these experiments were three to eight times larger by body weight than those used therapeutically in man, excepting of course, those cases in which the so called "massive mapharsen" therapy is employed. As was to be expected a moderate range of variation in susceptibility to the drug was noted in different dogs. In almost all cases, the dogs salivated and vomited within a few minutes after the administration of the drug, regardless of whether or not they had been protected by methionine.
We have divided the dogs into three main groups. The first represents those which were not protected with methionine; the second, those which were protected; and the third, those which were alternately protected and unpro-tected. The results show conclusively that the dogs which were protected did not develop liver damage as determined by the icteric index. These groups and the findings are discussed in greater detail below.
A control experiment was first run on one dog. This dog was maintained on the regular kennel ration of kitchen scraps, and during the period of the experiment, its plasma proteins varied from 5.79 gm. per cent to 6.89 gm. per cent. It was given three doses of mapharsen. The first dose, 0.003 gm. per kilo, caused no untoward reactions. Similarly, the second dose, 0.004 gm. per kilo given 14 days later and the third dose of 0.0045 gm. per kilo given 7 days after the second dose caused no jaundice or obvious toxic reactions. The dose was then increased to 0.007 gm. per kilo and the dog was found dead the next morning. At autopsy, the only noteworthy findings were pulmonary congestion and edema, atelectasis, slight hydrothorax, and congestion of the viscera. It will be noted from Table 1 that a dose of only 0.002 gm. per kilo was sufficient to cause a definite icterus in dog 42-171. After recovery a larger dose (0.0035 gm. per kilo) caused a more marked icterus. On the day following the second injection of the drug, the dog was found in vasomotor collapse. When it became apparent that it would not recover, it was sacrificed on the 4th day after injection. Autopsy revealed essentially normal appearing organs and the liver histologically showed only questionable cloudy swelling. A dose intermediary between the two used on 42-171 caused a definite icterus in 42-828, 42-846, and 42-728, and the last dog had to be put back on kennel ration on the 4th day after injection because its condition was poor. 42-828 and 42-846 were sacrificed on the 4th day after injection. In the gross and histologically the ~mrmOW~CE PROTECTS AGAINST MAPHARSEN LIVER INJURY organs were essentially normal except for alterations in the liver. Sections of the former showed fatty degeneration of the liver and those of the latter showed moderate evidence of injury of the cells in the peripheral portions of the liver lobules, the cell debris having been cleared away with collapse of the stroma. In 42-637, the same dose, 0.0025 gm. per kilo, only caused a slight trace of icterus on the 3rd day. This was evidently the lower border of the toxic dose for this individual dog. An increase of 0.0005 gm. per kilo in the dosage caused a definite icterus and the dog had to be put back on kennel ration on the 4th day after injection because of its poor condition. These results are in marked contrast with those of the following group in which protection of the liver was afforded by methionine ( Table 2) . The results shown in Table 2 are in sharp contrast to those in Table 1 . The clear-cut and consistent protection afforded by methionine is well shown here. In each case the methionine was given in the regular feeding the day prior to the administration of the drug. The dogs remained in excellent clinical condition and continued to take their feedings well throughout the course of injections. It should be noted that the last dose given in each instance is almost twice that which caused marked icterus in the unprotected dogs.
After receiving the protein-containing kennel ration for 15 days, the plasma proteins of 42-20 had risen to 5.65 gm. per cent and it was given 0.06 gm. per kilo of mapharsen unprotected and developed only a slight trace of icterus. Eight days later, the plasma proteins were 6.11 gm. per cent and it was given 0.008 gm. per kilo of mapharsen and developed no icterus. It was sacrificed 4 days later and at autopsy showed essentially normal organs. Dog 42-295 was subsequently given 0.0025 gm. per kilo of mapharsen unprotected causing slight icterus which disappeared in 3 days. Eight days later it was given 0.0035 gm. per kilo unprotected and developed an icterus of 4 on the 1st day. It is apparent that this animal could tolerate more of the drug than the other dogs could when unprotected. The dog was found dead 2 weeks after the last injection and at autopsy showed only slight atrophy of the liver cords in the central areas.
The sharp contrasts shown in Table 3 are similar to those seen between  Tables 1 and 2 , the only difference being that the same dog was alternately protected and unprotected. It can again be seen that the dog protected by 2 to 4 gm. of methionine in his feeding 24 hours before the mapharsen is given, can tolerate, without any obvious deleterious effect, almost twice the dose which causes liver damage in the unprotected state. This larger dose caused death when no methionine was given. At autopsy, 38-23 showed marked pulmonary congestion and edema with petechial hemorrhages on the pleural surfaces and 20 cc. of icteric fluid in each pleural cavity. The liver showed extensive fatty change and an occasional small area of necrosis. There were also numerous minute hemorrhagic areas in the medulla of each kidney. Dog 42-238 was subsequently given 0.0045 gm. per kilo of mapharsen with 1 gm. of methionine intravenously and found dead the following morning. This is more fully discussed below under the question of intravenous protection immediately proceeding the mapharsen. Dog 41-70 showed, at autopsy, extreme fatty change in the liver. Table 4 shows the variation in the protection received by giving 1 gm. of methionine intravenously immediately before the mapharsen. In two instances it afforded as complete protection with large doses of mapharsen, as when 2 to 4 gm. of methionine were given in the feeding the day before. In the other two, a marked icterus and a toxic death were the result, the methionine having had no significant protective effect when administered in this way. Dog 42-842 subsequently received complete protection to the same dose, 0.0045 gm. per kilo, by 3 gm. of methionine given in the feeding 24 hours before the mapharsen as already shown in Table 2 . The same is true of 42-238 which previously had received complete protection to 0.004 gm. per kilo from 4 gm. of methionine in the feeding 24 hours before mapharsen as already noted in Table 3 . Thus the administration of 1 gm. of methionine intravenously immediately before the injection of the mapharsen is not as reliable a method as giving 2 to 4 gin. of methionine in the feeding the day before the injection. This may be due simply to the smaller dosage.
At autopsy, 42-238 showed marked fatty change in the liver, pulmonary congestion and edema, and congestion and small hemorrhagic areas in the liver.
DISCUSSION
Mapharsen caused liver injury in these dogs for two reasons: the doses used were very large and the animals were in an abnormal state due to depletion of their protein stores. That the doses of drug were large is evident since the dose in man is approximately 0.001 gm. per kilo; whereas these dogs received amounts varying from 0.0025 to 0.0045 gin. per kilo. The state of protein depletion is an important factor as dogs which were unprotected by methionine developed icterus when 0.002 to 0.0025 gln. of mapharsen were given. In contrast dogs with normal protein stores tolerated 0.006 to 0.008 gm. per kilo without the development of liver injury. These massive doses may cause death however, due to the direct toxic effects of the drug.
From previous experience we have learned that study of the physiological function of the injured liver due to arsenical poisoning is a better index of the degree of dysfunction than histological examination of the organ. The anatomical findings are very variable and it is difficult from them alone to assay the degree of dysfunction. For this reason we did not sacrifice animals at the height of the injury but were content to judge it by the changes in the icteric index.
Study of the data indicates clearly that dogs whose protein stores are depleted are more susceptible to injury by arsenicals. However if these dogs were given methionine in their food 20 to 24 hours prior to the administration of the drug they were able to tolerate much larger amounts without developing icterus. Methionine given intravenously in 1 gm. doses immediately prior to the mapharsen was not adequate for uniform protection. Two dogs were protected but another dog developed severe icterus and another died a toxic death within 8 hours. It is fair to state that the amount of methionine given was smaller than the doses by mouth and perhaps larger amounts might have given adequate protection. We can conclude, however, that in these proteindepleted dogs methionine is protective against arsenical injury just as it was protective against chloroform liver damage.
Whether methionine will prove of any value to the clinician in this r61e has yet to be determined. From these data, however, we are able to emphasize again the importance of adequate protein stores in protecting the liver against toxic substances. These observations indicate that it is important that patients receiving arsenicals should be in the best possible nutritional state. It may be that liver damage due to arsenicals in some instances is the result of deficient protein stores. When liver damage has developed it is of the utmost importance that the patient not only receive carbohydrates but also adequate proteins in order that the best nutritional state for regeneration be obtained. If the patient is too ill to eat or retain food, plasma proteins and carbohydrates should be given parenteraUy.
SUMMARY
Depletion of body protein stores by means of low protein diet or plasmapheresis causes greater susceptibility to liver injury by the arsenical compound, mapharsen.
Normal dogs can tolerate mapharsen in doses of 0.006 to 0.008 gm. per kilo whereas in protein-depleted dogs doses of 0.002 to 0.0025 gm. per kilo cause liver injury with jaundice.
Methionine (2 to 4 gm.) given by mouth 20 to 24 hours prior to administration of mapharsen is protective and the dogs will tolerate 0.0045 gm. per kilo with no icterus developing.
